Fever and pain management in pediatrics: Paracetamol and NSAIDs safety insights :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

Chronic disease in children requires careful use of common painkillers

Fever and pain management in children Fever and pain management in children
Fever and pain management in children Fever and pain management in children

What's new?

Paracetamol and ibuprofen provide comparable fever and pain relief in children with chronic diseases, but safety risks vary according to comorbidities and clinical condition.

Fever and pain continue to represent two of the most common and clinically significant symptoms affecting children with infections and long-term medical disorders, frequently disrupting quality of life and increasing caregiver concern. Paracetamol and nonsteroidal anti-inflammatory drugs (NSAIDs), particularly ibuprofen, remain central to pediatric symptom management because of their established antipyretic, analgesic, and anti-inflammatory properties.

The review was undertaken to critically assess the efficacy and safety of paracetamol and NSAIDs in children with chronic illnesses and to provide clinically relevant guidance for optimizing fever and pain management in high-risk pediatric populations. A comprehensive narrative review was supported by expert clinical interpretation to evaluate current evidence surrounding the use of paracetamol and NSAIDs, with particular focus on ibuprofen, in children with chronic medical conditions.

Available literature examining therapeutic benefits, adverse-event profiles, contraindications, infection-related risks, and disease-specific safety considerations across multiple pediatric disorders was systematically reviewed. The findings were subsequently integrated with clinical expertise to formulate practical, evidence-informed recommendations for pediatric care. Paracetamol and ibuprofen showed similar potency in controlling fever and pain in chronic diseases.

  • Paracetamol remained the preferred first-line antipyretic and analgesic due to its favorable safety profile, though caution was advised in malnutrition, obesity, and neuromuscular disorders due to increased hepatotoxicity risk.
  • NSAIDs provided added anti-inflammatory benefit with similar analgesic effect but carried higher risks of gastrointestinal bleeding, renal injury, and coagulation-related complications in high-risk children.

They were contraindicated in dehydration, renal impairment, and nephrotic syndrome relapse, with strict caution required in neonates and medically fragile patients. The review highlighted that managing fever and pain in children with chronic diseases required an individualized and careful approach. It found that both paracetamol and NSAIDs were effective, but their safety depended on the child’s underlying health conditions and overall risk factors. A tailored treatment plan had helped balance good symptom relief with the prevention of possible side effects.

Source:

Children

Article:

Efficacy and Safety of Paracetamol and NSAIDs for Fever and Pain Management in Children with Chronic Diseases: A Narrative Review

Authors:

Gregorio Paolo Milani et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en
Try: